Cocrystal Pharma (COCP) News Today $1.58 +0.04 (+2.26%) As of 03:29 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock COCP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Zacks Small Cap Has Bullish Estimate for COCP Q3 EarningsAugust 23, 2025 | americanbankingnews.comCritical Survey: Cocrystal Pharma (NASDAQ:COCP) and Syndax Pharmaceuticals (NASDAQ:SNDX)August 21, 2025 | americanbankingnews.comCOCP: Norovirus Challenge Study to Initiate in 4Q25…August 19, 2025 | msn.comCocrystal Pharma reports Q2 EPS (20c), consensus (30c)August 14, 2025 | msn.comCocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsAugust 14, 2025 | globenewswire.comCocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical ConferenceAugust 5, 2025 | globenewswire.comCocrystal Pharma to Present Data from Phase 1 Study of First-in-Class ...July 11, 2025 | finance.yahoo.comCocrystal Pharma to Present Data from Phase 1 Study of First-in-Class Norovirus Protease Inhibitor CDI-988 at the 9th International Calicivirus ConferenceJuly 10, 2025 | globenewswire.comCocrystal Pharma Holds 2025 Annual Stockholders MeetingJuly 3, 2025 | theglobeandmail.comH.C. Wainwright lowers Cocrystal Pharma stock price target on dilutionJune 21, 2025 | investing.comCocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical ConferenceJune 6, 2025 | finance.yahoo.comCocrystal Pharma's Novel Norovirus Antiviral to be Presented at Department of Defense Medical ConferenceJune 5, 2025 | globenewswire.comCocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against the 2024 Highly Pathogenic H5N1 Avian Influenza StrainMay 29, 2025 | globenewswire.comCocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity ConferenceMay 28, 2025 | finance.yahoo.comCocrystal Pharma to Participate in Noble Capital Markets' 2025 Emerging Growth Virtual Equity ConferenceMay 28, 2025 | globenewswire.comCocrystal Pharma Reports First Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMay 15, 2025 | globenewswire.comCocrystal Pharma, Inc.: Cocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 VariantsApril 24, 2025 | finanznachrichten.deCocrystal Pharma's Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 VariantsApril 24, 2025 | globenewswire.comCocrystal Pharma Presents to Investment CommunityApril 23, 2025 | tipranks.comCocrystal Pharma to Present at Life Science Innovation Northwest 2025 ConferenceApril 16, 2025 | globenewswire.comOTC Markets Hosts Virtual Investor Presentation with Dr. Sam Lee, Co-CEO & President, and Jim Martin, Co-CEO & CFO, of Cocrystal Pharma, with David Bautz, PhD, Senior Analyst ...April 10, 2025 | msn.comCocrystal Pharma Approves 2025 Equity Incentive PlanApril 8, 2025 | tipranks.comCOCP: Norovirus Challenge Study Planned for 2025…April 2, 2025 | finance.yahoo.comCocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMarch 31, 2025 | globenewswire.comCocrystal Pharma to Participate in a Fireside Chat at the Zacks SCR Life Sciences Virtual Investor Forum on March 13, 2025March 6, 2025 | globenewswire.comCocrystal Pharma And 2 Other Promising US Penny Stocks To WatchFebruary 12, 2025 | finance.yahoo.comCocrystal Pharma, Inc. (COCP)January 14, 2025 | finance.yahoo.comCOCP: Phase 2a Trial of CC-42344 Extended…January 9, 2025 | finance.yahoo.comDow Dips Over 100 Points; Cocrystal Pharma Shares SlideDecember 31, 2024 | benzinga.comCocrystal Pharma Shares Fall After Flu-Treatment Study Is ExtendedDecember 31, 2024 | marketwatch.comCocrystal stock plunges 40% on influenza drug updateDecember 31, 2024 | seekingalpha.comCocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344December 31, 2024 | globenewswire.comCOCP stock touches 52-week high at $3.1 amid market optimismDecember 29, 2024 | investing.comCOCP: Multiple Upcoming Catalysts…November 19, 2024 | msn.comNovember 2024 US Exchange Standouts: Promising Penny StocksNovember 16, 2024 | nz.finance.yahoo.comCocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsNovember 13, 2024 | finance.yahoo.comHere's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn SituationOctober 18, 2024 | finance.yahoo.comCocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose CohortsSeptember 26, 2024 | finance.yahoo.comBuy Rating Affirmed for Cocrystal Pharma Amid Promising Drug Pipeline and Strong Clinical ResultsAugust 22, 2024 | markets.businessinsider.comCOCP: Topline Results from Phase 2a Study of CC-42344 in 2H24…August 19, 2024 | msn.comCocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment ConferencesAugust 19, 2024 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Cocrystal Pharma (COCP) and IGM Biosciences (IGMS)August 15, 2024 | markets.businessinsider.comCocrystal Pharma Reports Second Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsAugust 14, 2024 | stockhouse.comCocrystal Pharma Gets Positive Result From Phase 1 Study With CDI-988; Stock UpJuly 19, 2024 | markets.businessinsider.comCOCP: Phase 1 Single-Ascending Dose Cohort of CDI-988 Shows it is Safe and Well Tolerated…July 19, 2024 | msn.comCOCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…May 16, 2024 | finance.yahoo.comCOCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024May 13, 2024 | investorplace.comCocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development ProgramsMay 13, 2024 | globenewswire.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | finance.yahoo.comEnrollment Completed in Phase 2a Study with Cocrystal Pharma's Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal InfluenzaMay 1, 2024 | globenewswire.com Get Cocrystal Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for COCP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COCP Media Mentions By Week COCP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COCP News Sentiment▼0.860.99▲Average Medical News Sentiment COCP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COCP Articles This Week▼20▲COCP Articles Average Week Get the Latest News and Ratings for COCP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cocrystal Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GNTA News Today INMB News Today CUE News Today IMMX News Today SLGL News Today ALGS News Today ALXO News Today IVVD News Today ADVM News Today ANL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COCP) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cocrystal Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cocrystal Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.